Identification of Response Predictors to Capecitabine/Temozolomide in Metastatic Pancreatic Neuroendocrine Tumors

被引：0
|
作者：
Cives, Mauro [1 ]
Ghayouri, Masoumeh [1 ]
Brelsford, Marjorie [1 ]
Black, Michael [1 ]
Rizzo, Anthony [2 ]
Meeker, Alan [2 ]
Strosberg, Jonathan [1 ]
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[2] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
来源：
PANCREAS | 2016年 / 45卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：473 / 474
页数：2
相关论文
共 50 条
  • [1] Identification of response predictors to capecitabine/temozolomide in metastatic pancreatic neuroendocrine tumors
    Strosberg, Jonathan R.
    Cives, Mauro
    Brelsford, Marjorie
    Black, Michael
    Meeker, Alan
    Ghayouri, Masoumeh
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [2] Identification of response predictors to capecitabine/temozolomide in metastatic pancreatic neuroendocrine tumors
    Strosberg, Jonathan
    Cives, Mauro
    Brelsford, Marjorie
    Black, Michael
    Meeker, Alan
    Ghayouri, Masoumeh
    CANCER RESEARCH, 2015, 75
  • [3] Analysis of potential response predictors to capecitabine/temozolomide in metastatic pancreatic neuroendocrine tumors
    Cives, M.
    Ghayouri, M.
    Morse, B.
    Brelsford, M.
    Black, M.
    Rizzo, A.
    Meeker, A.
    Strosberg, J.
    ENDOCRINE-RELATED CANCER, 2016, 23 (09) : 759 - 767
  • [4] Neoadjuvant Capecitabine/Temozolomide for Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors
    Squires, Malcolm
    Worth, Patrick
    Konda, Bhavana
    Dillhoff, Manisha Shah Mary
    Abdel-Misih, Sherif
    Pawlik, Timothy
    Schmidt, Carl
    Poultsides, George
    Cloyd, Jordan
    PANCREAS, 2020, 49 (03) : 488 - 488
  • [5] The Role of Capecitabine/Temozolomide in Metastatic Neuroendocrine Tumors
    Ramirez, Robert A.
    Beyer, David T.
    Chauhan, Aman
    Boudreaux, J. Philip
    Wang, Yi-Zarn
    Woltering, Eugene A.
    ONCOLOGIST, 2016, 21 (06): : 671 - 675
  • [6] Neoadjuvant Capecitabine/Temozolomide (CAPTEM) for Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors
    Squires, M. H.
    Rossfeld, K. K.
    Konda, B.
    Shah, M.
    Dillhoff, M.
    Abdel-Misih, S.
    Pawlik, T.
    Cloyd, J.
    ANNALS OF SURGICAL ONCOLOGY, 2019, 26 : S138 - S139
  • [7] Capecitabine/Temozolomide Chemotherapy in Metastatic Neuroendocrine Tumors: Response Rate and Survival by Grade
    Thomas, Katharine
    Griffin, Ryan
    Voros, Brianne
    Boudreaux, J. Phillip
    Thiagarajan, Ramcharan
    Woltering, Eugene
    Ramirez, Robert
    PANCREAS, 2019, 48 (03) : 453 - 453
  • [8] Genomic correlates of response to capecitabine and temozolomide (CAPTEM) in pancreatic neuroendocrine tumors.
    Lee, Patrick
    Blais, Edik Matthew
    Gong, Jun
    Osipov, Arsen
    Moshayedi, Natalie
    Thomassian, Shant
    Ng, Camille
    Chuy, Jennifer W.
    Matrisian, Lynn McCormick
    Petricoin, Emanuel
    Pishvaian, Michael J.
    Hendifar, Andrew Eugene
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [9] Impact of Capecitabine and Temozolomide on the Primary Tumor in Pancreatic Neuroendocrine Tumors
    Guo, Jin
    Maxwell, Jessica
    Prakash, Laura
    Bhosale, Priya
    Morani, Ajaykumar
    Katz, Matthew H. G.
    Tzeng, Ching-Wei
    Ikoma, Naruhiko
    Kim, Michael
    Dasari, Arvind
    Yao, James C.
    Lee, Jeffrey E.
    Halperin, Daniel M.
    PANCREAS, 2022, 51 (03) : E37 - E37
  • [10] Peptide receptor radionuclide therapy versus capecitabine/ temozolomide for the treatment of metastatic pancreatic neuroendocrine tumors
    Gujarathi, R.
    Tobias, J.
    Azar, S. A.
    Keutgen, X.
    Liao, C-Y.
    ANNALS OF ONCOLOGY, 2024, 35 : S94 - S94
12345